In summary, deregulation of the G1-S (CCNE/CDK2) and G2-M transitions (CCNB1/CDK1) are probably most critical for the malignant potential of DLBCL (Fig. 5). The gene discussed is CCNE1; the disease is diffuse large B-cell lymphoma.